EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment

Hao Fu, Xiao Zheng, Ke Xu, Yuge Zhang, Mengxia Wu, Min Xu

BMC Gastroenterology · 2024

DOI: 10.1186/s12876-024-03313-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Hao Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China. 1808020318@stu.hrbust.edu.cn. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Nanoparticles, Glycyrrhizic Acid, Anti-Inflammatory Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 成都中医药大学,中国.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a persistent inflammatory condition that specifically targets the colon and rectum. Existing therapies fail to adequately address the clinical requirements of people suffering from this ailment. Despite the acknowledged potential of nanomedicines in the field of anti-inflammatory treatment, their widespread use in clinical settings is impeded by their expensive nature and the uncertainty surrounding their safety profiles. This study illustrates that two naturally occurring phytochemicals, Costunolide (COS) and Glycyrrhizic acid (GA), form carrier-free, multifunctional spherical nanoparticles (NPs) through noncovalent interactions, such as π–π stacking and hydrogen bonding. The COS-GA NPs displayed a synergistic anti-inflammatory effect, providing much more evidently improved therapeutic benefits for dextran sodium sulfate (DSS)-induced UC mice due to more effective reduction in inflammation and oxidative stress than did equal dosages of COS or GA used alone. In addition, COS-GA NPs have biocompatibility and biosafety properties unique to them. This study will serve as affirmation of the potential of COS-GA NPs as innovative natural anti-inflammatory and antioxidant activities and also such agents as drug discovery in UC, leading possibly to better outcomes in people living with this disabling condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeNanoparticlesGlycyrrhizic AcidAnti-Inflammatory AgentsDextran SulfateAnimalsMiceOxidative StressAntioxidantsDisease Models, AnimalMaleDrug SynergismSesquiterpenesLactones

Stichwörter der Autor:innen

Anti-inflammatoryAntioxidantCostunolideGlycyrrhizic acidSelf-assembled nanoparticlesUlcerative colitis

Substanzen

Glycyrrhizic AcidAnti-Inflammatory AgentsDextran SulfateAntioxidantsSesquiterpenescostunolideLactones

Autor:innen und Institutionen

  • Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China. 1808020318@stu.hrbust.edu.cn.
  • Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Förderung

  • 成都中医药大学,中国

Zitieren

APA

Fu, H., Zheng, X., Xu, K., Zhang, Y., Wu, M., & Xu, M. (2024). Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03313-9

Vancouver

Fu H, Zheng X, Xu K, Zhang Y, Wu M, Xu M. Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03313-9

BibTeX
@article{Fu2024,
  author = {Fu, Hao and Zheng, Xiao and Xu, Ke and Zhang, Yuge and Wu, Mengxia and Xu, Min},
  title = {Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment},
  journal = {BMC Gastroenterology},
  year = {2024},
  doi = {10.1186/s12876-024-03313-9}
}
Kostenlos starten →